Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PVX-410 |
Trade Name | |
Synonyms | PVX 410|PVX410 |
Drug Descriptions |
PVX-410 is a multipeptide vaccine that may stimulate anti-tumor immune response (PMID: 30128502). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C103823 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Durvalumab + Lenalidomide + PVX-410 | Durvalumab Lenalidomide PVX-410 | 0 | 1 |
Durvalumab + Poly ICLC + PVX-410 | Durvalumab PVX-410 Poly ICLC | 0 | 1 |
Durvalumab + PVX-410 | Durvalumab PVX-410 | 0 | 1 |
Lenalidomide + PVX-410 | Lenalidomide PVX-410 | 0 | 0 |
Melphalan + PVX-410 | Melphalan PVX-410 | 0 | 1 |
Pembrolizumab + PVX-410 | PVX-410 Pembrolizumab | 0 | 1 |
PVX-410 | PVX-410 | 0 | 0 |